Average price target from 18 ratings: $648.93 Average score: Sell Under Hold Over BuyFull Ratings StockGrader Rating: 57.29 HOLD Downgraded from BUY on 11/14/24 The Stock Looks Expensive, Especially Since Overall Fundamentals are Just Average Sentiment:9.08/10 POSITIVEFull Analysis Open $680.0...
Average price target from 15 ratings: $610.77 Average score: Sell Under Hold Over BuyFull Ratings StockGrader Rating: 57.29 HOLD Downgraded from BUY on 11/14/24 The Stock Looks Expensive, Especially Since Overall Fundamentals are Just Average Sentiment:9.14/10 POSITIVEFull Analysis Open $607.1...
Credit Suisse Group Lowers Axon Enterprise (NASDAQ:AXON) Price Target to $134.00 Financial News LiveJul 16, 2022 17:01 Axon Enterprise (NASDAQ:AXON) PT Lowered to $134.00 Defense WorldJul 14, 2022 21:22 Axon Enterprise (NYSE:AXON) Stock Price Down 1.2% Defense WorldJul 13, 2022 14:01 ...
In another report released on November 21, Bank of America Securities also maintained a Buy rating on the stock with a $750.00 price target. See Insiders’ Hot Stocks on TipRanks >> Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negat...
In a report released today, Meta Marshall from Morgan Stanley maintained a Hold rating on Axon Enterprise (AXON –Research Report), with a price target of $500.00. The company’s shares closed yesterday at $468.75. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with...
Looking at AXON’s recent outperformance, analysts remain strongly optimistic about its prospects. The stock has a consensus rating of “Strong Buy” from the 15 analysts covering it. However, as of writing, the company is trading above itsmean price target of $604.07. ...
Palantir price target raised to $44 from $37 at Mizuho VOO ETF Update, 12/13/2024 Baird Initiates Coverage of Palantir Technologies (PLTR) Stock with Neutral Rating Palantir initiated with Neutral on valuation at Baird Palantir initiated with a Neutral at Baird The views and opinions expre...
BioSymetrics primarily serves the pharmaceutical and healthcare sectors with its AI-driven target discovery and precision medicine programs. It was founded in 2015 and is based in Huntington, New York. Cloud Pharmaceuticals Cloud Pharmaceuticals, formerly TeraDiscoveries, is a leader in the ...
C.L. Lin et al. Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases. Future Med. Chem. 2012, 4, 1689-1700. Order SizeUnit PriceStock 10 mg€90.00In Stock 50 mg€320.00In Stock Need more?Bulk Inquiry ...
One shot on target during the entire game? Good grief, Enzo Maresca. As I exited past the padded seats, I wondered if I might need a padded cell in the coming weeks and months. I was aware that a few players were walking towards the away end, but I turned my back to them and ...